While these glycans mask the conserved neutralizing antibody epitopes on HIV-1 Env [1, 7, 8], they can also be targeted by broadly neutralizing antibodies (bnAbs) that are generated in a fraction of HIV-1-infected individuals after many years of infection [9, 10]. This evidence concerns the gene ERVW-1 and infection.